Cancer Genome Sequencing

Бостон, США 4 6 декабря / 2012

Посетителям

Получите билет на выставку. Выберите необходимое количество билетов, заполните короткую форму и получите билеты на e-mail.

Tickets
  Цена Кол-во

Бесплатный билет

Бесплатно 1 +
Получить билетыКупить билеты

К сожалению, билеты закончились, но у нас есть другие выставки, которые вы можете посетить.

июн 9 – 11 09 июн 201711 июн 2017
Выставка

China Preschool Education Conference 2017&The 8th Internaitonal Kid's Education Expo

Китай, Гуанчжоу
China Preschool Education Conference 2017 & The 8th International Kid's Education Expo – важнейшая интеллектуальная платформа для презентации научных...
июн 16 – 18 16 июн 201718 июн 2017
Выставка

China International Education Equipment Expo 2017

Китай, Цзинань
China International Education Equipment Expo 2017 – одна из наиболее мощных интеллектуальных платформ в Китае.Ведущие компании представят научные концепты...
Бесплатно
ноя 23 – 25 23 ноя 201725 ноя 2017
Выставка

China International Education Equipment & IT Solutions Exhibition

Китай, Пекин
China International Education Equipment & IT Solutions Exhibition – профессиональная интеллектуальная платформа для участников индустрии науки и...

Это мероприятие уже закончилось.

Вы можете подобрать другие интересные события в нашем календаре, или воспользоваться поиском:

О конференции

Cancer Genome Sequencing

 

TTrTranslating the cancer genome into better drug and diagnostic development

6-8 December,
Boston

 

www.cancergenome-sequencing.com

 

The World’s Largest and Most Influential Cancer Genome Sequencing Meeting for Drug and Diagnostic Developers

It took 50 years and over $3bn to fully sequence the human genome, following Watson and Crick’s 1953 groundbreaking discovery on the structure of DNA.

With advances in sequencing technologies, the goal of sequencing a genome in 24 hours costing as little as $1000 is fast becoming a reality. 

Cancer is a disease of the genome.

Understanding and exploiting this has been the goal of scientists for decades but only with the revolution in ease of sequencing, are major strides being made. With inexpensive sequencing helping drive innovation the next hurdle to overcome lies within translation.

How can I use the information gleaned from cancer genome sequencing to optimize the development of better and more personalized anticancer therapies?

Who’s doing this work and how easy is it to turn better understanding into better drug development? Imagine yourself in a room crowded with scientists from the leading pharma, biotech and academic organizations all speaking about current cancer genome projects. 

The Cancer Genome Sequencing meeting is the world’s only commercially focussed meeting dedicated to helping drug developers overcome challenges in bridging the gap between cancer genome sequencing and the development of personalized therapies. Computational biology, translational sciences and cancer genomics experts at the likes of Novartis, Genentech and Pfizer will be debating the optimal approaches to bioinformatics, target identification and clinical development.

Key themes being explored at Cancer Genome Sequencing

·         Analysis of sequence information is hard to coordinate, expensive and time consuming –  so how are Pfizer and Novartis processing data and transforming it in to clinical applications? 

·         What are the best strategies currently being used in industry for incorporating knowledge of the cancer genome into the development of better cancer drugs? Hear from industry experts at AstraZeneca, Merck, Genentech and MedImmune

·         How are researchers at Merck distinguishing between driver and passenger mutations, and what do these mean for drug development?

·         Discover how novel adaptive trials are being used by Daiichi Sankyo to integrate cancer genome information

·         Get updates on the leading cross industry efforts like the Cancer Cell Line Encyclopedia, Cancer Genome Atlas and Clinical Proteomic Tumor Analysis Consortium

·         Approaches for optimizing bioinformatics analysis, translation and storage for aiding drug discovery are highlighted Novartis, Merck and BIDMC

 

For more information, simply:

 

 Call: +1 212 537 5898

Email: info@hansonwade.com            

Visit: www.cancergenome-sequencing.com

 

 

 

Узнать большеСвернуть

Место проведения

Адрес: Бостон, США
Сравните цены на отели и выберите лучший вариант среди 9 систем бронирования:
Отели рядом

Организаторам

Привлекайте клиентов на свои бизнес-мероприятия с ExpoPromoter

Партнёрам

Зарабатывайте с ExpoPromoter, привлекая клиентов на мероприятия